Evidence map›Paper›PMID 25833703›Full record

ArticleJournal of human hypertension2016

Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension.

O Petrák, T Zelinka, B Štrauch, J Rosa, Z Šomlóová, T Indra, H Turková, R Holaj, J Widimský

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human hypertension, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Observational
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Observational
  7. Observational
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

O Petrák3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
T Zelinka3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
B Štrauch3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
J Rosa3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
Z Šomlóová3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
T Indra3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
H Turková3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
R Holaj3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
J Widimský3rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
Charles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to analyze the clinical use of different types of combination therapy in a large sample of consecutive patients with uncontrolled hypertension referred to Hypertension Centre. We performed a retrospective analysis of combination antihypertensive therapy in 1254 consecutive patients with uncontrolled hypertension receiving at least triple-combination antihypertensive therapy. Among the most prescribed antihypertensive classes were renin-angiotensin blockers (96.8%), calcium channel blockers (82.5%), diuretics (82.0%), beta-blockers (73.0%), centrally acting drugs (56.0%) and urapidil (24.1%). Least prescribed were spironolactone (22.2%) and alpha-1-blockers (17.1%). Thiazide/thiazide-like diuretics were underdosed in more than two-thirds of patients. Furosemide was prescribed in 14.3% of patients treated with diuretics, while only indicated in 3.9%. Inappropriate combination therapy was found in 40.4% of patients. Controversial dual and higher blockade of renin-angiotensin system occurred in 25.2%. Incorrect use of a combination of two antihypertensive drugs with the similar mechanism of action was found in 28.1%, most commonly a combination of two drugs with central mechanism (13.5%). In conclusion, use of controversial or incorrect combinations of drugs in uncontrolled hypertension is common. Diuretics are frequently underdosed and spironolactone remains neglected in general practice. The improper combination of antihypertensive drugs may contribute to uncontrolled hypertension.

Indexed as

Antihypertensive AgentsCzech RepublicDrug Therapy, CombinationFemaleHumansHypertensionMaleMiddle AgedPractice Patterns, Physicians'Retrospective StudiesTreatment OutcomeAntihypertensive Agents

Identifiers

PMID25833703
OpenAlexW2093825041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.